Latest Breaking News On - Japan heart foundation - Page 1 : comparemela.com

Although the open-label trial has many limitations, it could add some support to findings from the REDUCE-IT study, which showed a reduction in cardiovascular events with high-dose eicosapentaenoic acid.

United statesDeepak bhattPamr taubSteve nissenHiroyuki daidaAmerican heart associationJuntendo university graduate school of medicineJapan heart foundationScientific sessionsJuntendo university graduate schoolMedscape cardiologyIntervention studyCleveland clinicSecondary prevention efficacyCombination therapy statinLate breaking clinical trials